Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multip... (mal responses was as previouslyreported ...)

HOME >> MEDICINE >> TECHNOLOGY

Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma

Date:9/6/2007

mal responses was, as previously reported, 44% (18 out of 41 patients evaluable for response). Of the 18 responding patients (44%), 8 out of 14 patients were bortezomib-nave (57%); 7 out of 16 patients were bortezomib-pretreated patients (44%); and 3 out of 11 patients were bortezomib-refractory (27%). Responses in the bortezomib-refractory patients continue to show prolonged duration (at least 10 months at the time of data presentation at ASCO in June 2007) and meaningful reduction of serum/urinary M-protein (greater than 89%). The combination of tanespimycin and bortezomib was well-tolerated.

Kosan has been granted orphan drug designation for tanespimycin in multiple myeloma in both the US and European Union.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Kosan is leveraging its proprietary discovery platform to generate a pipeline of potentially significant product candidates, primarily in the area of oncology.

Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Tanespimycin (KOS-953) is being tested in combination with bortezomib in patients with multiple myeloma in a registration program called TIME. Tanespimycin is also being studied in HER2-positive metastatic breast cancer in combination with Herceptin, and as monotherapy in metastatic melanoma. Intravenous and oral formulations of Kosan's second-generation Hsp90 inhibitor, alvespimycin (KOS-1022), are being evaluated in Phase 1 clinical trials in hematological cancers and in HER2-positive metastatic breast cancer.

Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's epothilone program is partnered with R
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
2. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
3. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
4. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
5. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
6. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
7. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
8. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
9. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
10. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
11. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia

Post Your Comments:

(Date:12/15/2009)... 15 Ever wonder what something looks like ... makers of the Personal Scanning Electron Microscope (PSEM), kicked ... to send in samples to be scanned by one ... a scan range of 100nm to 5mm and an ... samples into focus. In addition, ASPEX will not only ...

(Date:12/15/2009)... find the best plan at the right price ... the end of the year, thousands of Nebraska Medicare ... coverage. This is when the state,s 268,000 Medicare ... sign up and pay for in 2010. ,, ... decision, says Independent Retail Pharmacist Steve Osenbaugh, of Lincoln. ...

(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Surgical ... the U.S. and its International Trade ... http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The just released ... Instrument Manufacturing Industry report is the ...

Breaking Medicine Technology:ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2 Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7 Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8 UBC researchers find key microbial indicator of ocean health 10508 1 UBC researchers find key microbial indicator of ocean health 10508 2 Sandia SRC win LES award for NINE program outreach 14575 1 Sandia SRC win LES award for NINE program outreach 14575 2 Berkeley researchers find new route to nano self assembly 14573 1 Berkeley researchers find new route to nano self assembly 14573 2 Berkeley researchers find new route to nano self assembly 14573 3 Berkeley researchers find new route to nano self assembly 14573 4

[0] ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign [0] Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans [0] Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]

... placed in the brain to treat a stroke as it,s ... International Symposium on Endovascular Therapy (ISET).Stents have long been used ... prevent heart attacks and in the neck to prevent strokes. ... treat occurring heart attacks by opening up the blocked arteries. ...

... - New Funds to Drive Clinical Development ... Cardio3 BioSciences, a leading Belgian ... cardiovascular diseases, has,raised EUR7.2 million in a successful Series ... from a range of new and existing investors, will ...

Other Medicine Technology:Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research 2 Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research 3 Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 2 Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 3 Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 4 Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding 5

Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding

(Date:12/15/2009)... combined with developmental changes increases risk in teens, study ... teenagers, being overweight or obese increases the risk of ... to be true for younger children, Australian researchers have ... children, aged 2 to 18, who were referred for ... researchers found that among those aged 12 and older ...

(Date:12/15/2009)... for injury when doctors decide benefits of imaging outweigh ... MRI scans can pose a serious risk to people ... Drug Administration researchers exposed pacemakers to a simulated MRI ... at the tip of the pacemaker lead, where it ... The exposure to MRI magnetic pulses caused certain pacemakers ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... Manufacturing Industry in the U.S. and ... ,, http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, ... Manufacturing Industry report provides the latest ...

(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... Cardiovascular Diseases Therapeutics - Market Forecasts ... and Deals Analysis ,, ... ,, The author has released its ...

(Date:12/15/2009)... Research shows a direct correlation between effective workplace ... a culture of health improvement can result in ... new white paper from The Vitality Group, a ... an ideal setting for the delivery of health ... corporate culture of health is a critical component ...

[0] Puberty May Trigger Sleep Apnea in Overweight Kids [0] Patients With Pacemakers Should Avoid MRI Scans [0] Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition][0] Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Optimizing Corporate Culture is Critical to the Success of Wellness Programs

... The American,Veterinary Medical Association (AVMA) commends the U.S. ... (VWGP) as part of the 2007 Farm,Bill. This ... supply of public health and food safety veterinarians ... important to rural families, rural,communities and the nation ...

... December 19, 2007 Heart attacks among cigarette smokers ... A common defect in a gene controlling cholesterol metabolism ... to a new study in Annals of Noninvasive Electrocardiology. ... normally have heart attacks no sooner than their non-smoking ...

... investigators have discovered that immune system cells that engulf ... this task from a common housekeeping mechanism that most ... that is likely to help researchers understand how the ... can resist chemotherapy drugs before they have a chance ...

... MAYA Steps Up by Helping Latino Nonprofits and ... Will Feature a DC Latino with,HIV., WASHINGTON, ... by MAYA:, What: This holiday season, MAYA ... offering HIV/AIDS programs to the Latino community.,MAYA will ...

... application process were offered,coverage, WASHINGTON, Dec. 19 ... market released today by America,s,Health Insurance Plans (AHIP) ... affordable than is widely known. The survey found ... coverage, and that,consumers have access to a wide ...

... inefficient way our bodies replace worn-out cells is a defense ... cell just split into two identical daughter cells would seem ... apart. , However that would be a recipe ... of Arizona in Tucson. , "If there were only one ...

Other Medicine News:Health News:AVMA Lauds Senators for Approving 2007 Farm Bill Legislation that Includes the Veterinary Workforce Grant Program 2 Health News:St. Jude finds link between cellular defense processes, showing how cancer cells survive 2 Health News:St. Jude finds link between cellular defense processes, showing how cancer cells survive 3 Health News:HIV/AIDS Rate Increases in DC Area Latino Population, Community Lacks Resources 2 Health News:New AHIP Survey Finds Individual Health Care Coverage Accessible and Affordable 2 Health News:New AHIP Survey Finds Individual Health Care Coverage Accessible and Affordable 3 Health News:Why don't we get cancer all the time? 2

AVMA Lauds Senators for Approving 2007 Farm Bill Legislation that Includes the Veterinary Workforce Grant Program Heart attack risk from smoking due to genetics St. Jude finds link between cellular defense processes, showing how cancer cells survive HIV/AIDS Rate Increases in DC Area Latino Population, Community Lacks Resources New AHIP Survey Finds Individual Health Care Coverage Accessible and Affordable Why don't we get cancer all the time?

The Trident ceramic acetabular system provides several important benefits and meets greater demands of younger, more active patients....

Optimal solution for normal acetabulum and younger patients....

The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....

BatCup cotyloid implant, designed for use in revision surgery, is an hemispherical metal cup, with grooves on the edges that house locking flanges, which are attached to the iliac bone by cancellous ...

Medicine Products:

Trident Ceramic Acetabular System RM metal-on-metal cup Cox Comb Cup BatCup - Revision Cup

Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multip...(mal responses was as previouslyreported ...),Health